Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: ctirry who wrote (2882)	5/26/1998 4:21:00 PM
From: jelrod3	Read Replies (1) \| Respond to of 9523

What Dr. Gordon says is not what I'm hearing from an informal survey of 10 cardiologists practicing in my city. They all say that Lipitor is better than the rest, and have cited me to other studies/anecdotal experience. In my own particular case, I was on Pravachol, and was switched to Lipitor, with marked improvement in my cholesterol profile, and a more favorable lowering of my liver enzymes to boot. My wife had a similar experience. I think Lipitor is, or will be , the drug of choice for hypercholesterolnemia.